- Home
- ABSI vs TKNO Comparison
ABSI vs TKNO Comparison
Compare ABSI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- TKNO
- Stock Information
- Founded
- ABSI 2011
- TKNO 1996
- Country
- ABSI United States
- TKNO United States
- Employees
- ABSI N/A
- TKNO N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- ABSI Health Care
- TKNO Health Care
- Exchange
- ABSI Nasdaq
- TKNO Nasdaq
- Market Cap
- ABSI 338.0M
- TKNO 256.9M
- IPO Year
- ABSI 2021
- TKNO 2021
- Fundamental
- Price
- ABSI $2.39
- TKNO $4.35
- Analyst Decision
- ABSI Strong Buy
- TKNO
- Analyst Count
- ABSI 5
- TKNO 0
- Target Price
- ABSI $7.98
- TKNO N/A
- AVG Volume (30 Days)
- ABSI 4.4M
- TKNO 224.0K
- Earning Date
- ABSI 08-12-2025
- TKNO 08-07-2025
- Dividend Yield
- ABSI N/A
- TKNO N/A
- EPS Growth
- ABSI N/A
- TKNO N/A
- EPS
- ABSI N/A
- TKNO N/A
- Revenue
- ABSI $4,138,000.00
- TKNO $38,923,000.00
- Revenue This Year
- ABSI $44.71
- TKNO $9.52
- Revenue Next Year
- ABSI $374.26
- TKNO $15.20
- P/E Ratio
- ABSI N/A
- TKNO N/A
- Revenue Growth
- ABSI 27.32
- TKNO 11.40
- 52 Week Low
- ABSI $2.01
- TKNO $4.00
- 52 Week High
- ABSI $6.33
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- ABSI 33.33
- TKNO 43.35
- Support Level
- ABSI $2.50
- TKNO $4.22
- Resistance Level
- ABSI $2.73
- TKNO $4.94
- Average True Range (ATR)
- ABSI 0.18
- TKNO 0.29
- MACD
- ABSI -0.04
- TKNO -0.00
- Stochastic Oscillator
- ABSI 1.94
- TKNO 16.75
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.